Undervalued Biotech's

Description:

With the merger between Pfizer (PFE) and Wyeth (WYE), the attempted takeover of Genentech (DNA) by Roche, and the overall positive action in Amgen (AMGN), Celgene Corp (CELG), Genzyme (GENZ), and Geilead (GILD) recently, many analysts and investors believe that 2009 will be a positive year for the biotech industry as a whole.
Important events in the biotech space include Dendreon’s (DNDN) binary data announcement on its key drug Provenge in early April and Genentech’s (DNA) update on various uses for Avastin late April.

Most Viewed Portfolios

View All

Articles

4 Tech Stocks Under $10 Spiking Higher

05.23.13 | 02:46 PM

MADISON, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage...

3 Big Stocks on Traders' Radars

05.23.13 | 02:50 PM

BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of gen...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter